Hongqi Liu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0002-8564-0247

发表论文 112 篇 · 总被引 5455 次 · h-index 31

代表论文

• Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients (2021 · Signal Transduction and Targeted Therapy · 被引 211)
• Advanced Zinc Anode with Nitrogen‐Doping Interface Induced by Plasma Surface Treatment (2021 · Advanced Science · 被引 101)
• Advanced Flexible Carbon-Based Current Collector for Zinc Storage (2022 · Advanced Fiber Materials · 被引 59)
• Channel engineering strategy of precisely modified MOF/nanofiber composite separator for advanced aqueous zinc ion batteries (2024 · Composites Part B Engineering · 被引 51)
• Nano‐scale BN interface for ultra‐stable and wide temperature range tolerable Zn anode (2022 · EcoMat · 被引 46)
• Human transferrin receptor can mediate SARS-CoV-2 infection (2024 · Proceedings of the National Academy of Sciences · 被引 45)